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Electronic cigarettes have rapidly become the consumer preferred alternative to 
tobacco cigarettes, but very little is known about the harms associated with their 
use. Electronic cigarettes are often proposed as a cessation device  from a harm 
reduction standpoint, but this overlooks the lack of evidence for reduced harms and 
the numerous new vapers who have never smoked that are exposed to harms they 
otherwise would have avoided. Studies within this thesis provide essential evidence 
in the harm reduction debate. 
 
In Chapter 3 we surveyed perceptions of young Australians towards E-cigarettes. 
We hypothesised that they would believe E-cigarettes to be less harmful than 
tobacco cigarettes, and that they would be misinformed about E-cigarette 
regulations in Australia due to a lack of education from regulatory bodies. In 
Chapters 4, 5 and 6 of this thesis we used in vitro models of exposure to determine 
potential health risks associated with E-cigarette use. Chronic obstructive 
pulmonary disease (COPD) patients have been identified as a high-risk population of 
E-cigarette users, hence our studies focused on the potential effect E-cigarette 
exposure may have on mechanisms related to the underlying pathophysiology of 
COPD. 
 
In Chapter 4, we developed an in vitro E-cigarette exposure model to determine the 
cytotoxic and inflammatory effects of E-cigarette exposure in COPD and non-COPD 
primary human airway smooth muscle cells. In this study we confirmed earlier 
suspicions on cytotoxicity and provided the first evidence that COPD cells are hyper-
responsive to E-cigarettes. In Chapter 5 we provided the first evidence that E-
cigarettes have the potential to induce cellular senescence. This finding gives 
further support to avoiding use of E-cigarettes in COPD patients, given the role 
cellular senescence plays in COPD pathophysiology. In Chapter 6 we provided 
evidence that combined cigarette and E-cigarette use is significantly more harmful 
than using either product alone. Furthermore, we found that the inflammatory 
response induced by dual exposure was glucocorticoid resistant. Glucocorticoid 
 XXII 
resistance is one of the hallmarks of COPD, and thought to contribute to 
uncontrolled inflammation in pre-COPD (symptomatic smokers) so dual use should 
be avoided.  
 
Importantly, this thesis elucidates pathological harms associated with E-vapour 
exposure. The evidence provided in the studies within this thesis should be used to 
inform clinicians, researchers and patients on the harms associated with E-cigarette 
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